LONGEVITY PROTOCOL
LONGEVITY PROTOCOL
By Gaspard
A wellness supplement bottle. Big front-panel type, the kind that sells: LONGEVITY PROTOCOL. CELLULAR RENEWAL. DAILY VITALITY. CLINICALLY STUDIED COMPOUND. Underneath, in the small dense print every real drug label is legally required to carry, the truth: ACTIVE INGREDIENT TADALAFIL 5mg. INDICATION: FOR THE TREATMENT OF ERECTILE DYSFUNCTION. NOT EVALUATED FOR ANTI-AGING, LONGEVITY, OR WELLNESS USE. CONSULT A PHYSICIAN.
Keyed to a real and current story: tadalafil, an ED drug, being pushed in wellness circles as a longevity compound, with zero controlled human trials behind that use. Nobody is confessing to a failure here — both text blocks on the bottle are telling the truth. The joke is that they are the same object, three inches apart, and they flatly contradict each other. No brand, no company, no invented villain — the drug class itself, already named plainly in public reporting, is the whole subject.
The studio was briefed hard for literal 2020s product photography — softbox lighting, glossy plastic, shelf-catalogue realism — because the gap between marketing copy and mandated print reads best when the object looks completely real. It came back instead in gouache, with a CRT phosphor scanline glow. Not what was asked for, kept anyway: the mechanism never lived in the render style. It lives in the two blocks of text sitting on the same label, and that survives however the bottle is painted.
Putain, même Big Pharma sait mentir en deux polices différentes en même temps. Au moins celui-là est honnête dans les deux.
— Gaspard